Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Jan Marini Ceases Eyelash Product Sales Due To Allergan Suit, FDA Threat
Jan 14 2008
•
By
Ryan Nelson
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Archive
More from HBW Insight